Strata Critical Medical, Inc (SRTA) insider trading

Every open-market stock purchase and sale by Strata Critical Medical, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Insiders sold $898K over the last 12 months (8 sales).
  • Last insider buy: William A. Heyburn (CEO), $76K, 10 months ago.

Last 12 months: insiders bought $97.9K (2 buys) and sold $898K (8 sales). Last close $5.87 on Jun 7, 2026.

Recent SRTA insider trades

DateInsiderTradeValue
Jun 8, 2026William A. Heyburn (CEO)Sold (not open market)$186K
Jun 8, 2026William A. Heyburn (CEO)Sold$186K
Jun 8, 2026Melissa M. Tomkiel (CEO)Sold$175K
Jun 8, 2026Melissa M. Tomkiel (CEO)Sold (not open market)$175K
Jun 8, 2026Scott M Wunsch (CEO)Sold (not open market)$32.6K
Jun 8, 2026Scott M Wunsch (CEO)Sold$32.6K
Jun 8, 2026Amir Cohen (C-suite exec)Sold$27.3K
Jun 8, 2026Amir Cohen (C-suite exec)Sold (not open market)$27.3K
May 22, 2026Amir Cohen (C-suite exec)Sold$240K
May 21, 2026Amir Cohen (C-suite exec)Sold$59.6K
May 11, 2026Amir Cohen (C-suite exec)Sold$82.8K
May 7, 2026Velibor Krstic (10% owner)Sold (not open market)—
Apr 24, 2026Melissa M. Tomkiel (CEO)Sold (not open market)$1.6M
Apr 24, 2026William A. Heyburn (CEO)Sold (not open market)$1.5M
Apr 24, 2026Amir Cohen (C-suite exec)Sold (not open market)$202K
Apr 24, 2026Scott M Wunsch (CEO)Sold (not open market)$68.5K
Apr 23, 2026Amir Cohen (C-suite exec)Bought (not open market)—
Apr 23, 2026William A. Heyburn (CEO)Bought (not open market)—
Apr 23, 2026Melissa M. Tomkiel (CEO)Bought (not open market)—
Apr 23, 2026Scott M Wunsch (CEO)Bought (not open market)—
Mar 16, 2026Scott M Wunsch (CEO)Bought (not open market)—
Mar 8, 2026William A. Heyburn (CEO)Sold (not open market)$142K
Mar 8, 2026Melissa M. Tomkiel (CEO)Sold (not open market)$133K
Mar 8, 2026Scott M Wunsch (CEO)Sold (not open market)$16.5K
Mar 8, 2026Amir Cohen (C-suite exec)Sold (not open market)$11K

Who's trading SRTA

Get free alerts when an insider at Strata Critical Medical, Inc files a new trade →